Heidi Cartwright

1.9k total citations
17 papers, 1.5k citations indexed

About

Heidi Cartwright is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Heidi Cartwright has authored 17 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Neurology, 7 papers in Cellular and Molecular Neuroscience and 4 papers in Molecular Biology. Recurrent topics in Heidi Cartwright's work include Parkinson's Disease Mechanisms and Treatments (12 papers), Neurological disorders and treatments (9 papers) and Botulinum Toxin and Related Neurological Disorders (4 papers). Heidi Cartwright is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (12 papers), Neurological disorders and treatments (9 papers) and Botulinum Toxin and Related Neurological Disorders (4 papers). Heidi Cartwright collaborates with scholars based in Australia, South Africa and United States. Heidi Cartwright's co-authors include Glenda M. Halliday, Jillian J. Kril, Mojmír Svoboda, Heather McCann, D.A. McRitchie, J. M. Henderson, Claire H. Stevens, John G. Morris, Kimberly L. H. Carpenter and Craig D. Hardman and has published in prestigious journals such as Neurology, Annals of Neurology and Neuroscience.

In The Last Decade

Heidi Cartwright

17 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Heidi Cartwright Australia 15 976 659 264 258 249 17 1.5k
Antony J. Harding Australia 15 653 0.7× 319 0.5× 250 0.9× 444 1.7× 214 0.9× 22 1.3k
Franck Durif France 22 1.2k 1.2× 524 0.8× 208 0.8× 140 0.5× 230 0.9× 69 1.5k
E.N.H. Jansen Netherlands 17 782 0.8× 363 0.6× 193 0.7× 289 1.1× 170 0.7× 33 1.2k
Cliff Shults United States 11 996 1.0× 410 0.6× 210 0.8× 245 0.9× 235 0.9× 12 1.4k
Anne M. Landau Denmark 21 431 0.4× 494 0.7× 117 0.4× 276 1.1× 156 0.6× 81 1.2k
T. Caraceni Italy 26 1.3k 1.3× 714 1.1× 217 0.8× 121 0.5× 188 0.8× 90 1.8k
Frederic Sampedro Spain 21 654 0.7× 472 0.7× 344 1.3× 278 1.1× 125 0.5× 60 1.4k
Subrata K. Bose United Kingdom 14 673 0.7× 343 0.5× 379 1.4× 86 0.3× 311 1.2× 18 1.6k
Carrie G. Markgraf United States 16 491 0.5× 434 0.7× 156 0.6× 164 0.6× 310 1.2× 28 1.5k
A. Laihinen Finland 21 806 0.8× 611 0.9× 308 1.2× 79 0.3× 88 0.4× 38 1.3k

Countries citing papers authored by Heidi Cartwright

Since Specialization
Citations

This map shows the geographic impact of Heidi Cartwright's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heidi Cartwright with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heidi Cartwright more than expected).

Fields of papers citing papers by Heidi Cartwright

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heidi Cartwright. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heidi Cartwright. The network helps show where Heidi Cartwright may publish in the future.

Co-authorship network of co-authors of Heidi Cartwright

This figure shows the co-authorship network connecting the top 25 collaborators of Heidi Cartwright. A scholar is included among the top collaborators of Heidi Cartwright based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heidi Cartwright. Heidi Cartwright is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
McCann, Heather, Heidi Cartwright, & Glenda M. Halliday. (2015). Neuropathology of α‐synuclein propagation and braak hypothesis. Movement Disorders. 31(2). 152–160. 92 indexed citations
2.
McCann, Heather, Claire H. Stevens, Heidi Cartwright, & Glenda M. Halliday. (2013). α-Synucleinopathy phenotypes. Parkinsonism & Related Disorders. 20. S62–S67. 271 indexed citations
3.
Henderson, J. M., et al.. (2000). Degeneration of the centr� median-parafascicular complex in Parkinson's disease. Annals of Neurology. 47(3). 345–352. 126 indexed citations
4.
Opeskin, Kenneth, Renate M. Kalnins, Glenda M. Halliday, Heidi Cartwright, & Samuel F. Berkovic. (2000). Idiopathic generalized epilepsy. Neurology. 55(8). 1101–1106. 36 indexed citations
5.
Henderson, J. M., Kimberly L. H. Carpenter, Heidi Cartwright, & Glenda M. Halliday. (2000). Degeneration of the centré median-parafascicular complex in Parkinson's disease.. PubMed. 47(3). 345–52. 141 indexed citations
6.
Henderson, J. M., et al.. (2000). Degeneration of the centré median–parafascicular complex in Parkinson's disease. Annals of Neurology. 47(3). 345–352. 7 indexed citations
7.
Halliday, Glenda M., Susan M. Pond, Heidi Cartwright, et al.. (1999). Clinical and Neuropathological Abnormalities in Baboons Treated with HPTP, the Tetrahydropyridine Analog of Haloperidol. Experimental Neurology. 158(1). 155–163. 15 indexed citations
8.
McRitchie, D.A., et al.. (1998). The midbrain dopaminergic cell groups in the baboon papio ursinus. Brain Research Bulletin. 47(6). 611–623. 15 indexed citations
9.
Kril, Jillian J., Glenda M. Halliday, Mojmír Svoboda, & Heidi Cartwright. (1997). The cerebral cortex is damaged in chronic alcoholics. Neuroscience. 79(4). 983–998. 430 indexed citations
10.
Hardman, Craig D., Glenda M. Halliday, D.A. McRitchie, Heidi Cartwright, & John G. Morris. (1997). Progressive Supranuclear Palsy Affects both the Substantia Nigra Pars Compacta and Reticulata. Experimental Neurology. 144(1). 183–192. 51 indexed citations
11.
McRitchie, D.A., Heidi Cartwright, & Glenda M. Halliday. (1997). Specific A10 Dopaminergic Nuclei in the Midbrain Degenerate in Parkinson's Disease. Experimental Neurology. 144(1). 202–213. 110 indexed citations
12.
Halliday, Glenda M., D.A. McRitchie, Heidi Cartwright, et al.. (1996). Midbrain neuropathology in idiopathic Parkinson's disease and diffuse Lewy body disease. Journal of Clinical Neuroscience. 3(1). 52–60. 82 indexed citations
13.
Cullen, Karen M., Glenda M. Halliday, Heidi Cartwright, & Jillian J. Kril. (1996). Improved Selectivity and Sensitivity in the Visualization of Neurofibrillary Tangles, Plaques and Neuropil Threads. PubMed. 5(2). 177–187. 19 indexed citations
14.
Hardman, Craig D., D.A. McRitchie, Glenda M. Halliday, Heidi Cartwright, & John G. Morris. (1996). Substantia Nigra Pars Reticulata Neurons in Parkinson's Disease. 5(1). 49–55. 51 indexed citations
15.
Halliday, Glenda M., Lesley Davies, D.A. McRitchie, et al.. (1995). Ubiquitin-positive achromatic neurons in corticobasal degeneration. Acta Neuropathologica. 90(1). 68–75. 33 indexed citations
16.
McRitchie, D.A., Glenda M. Halliday, & Heidi Cartwright. (1995). Quantitative analysis of the variability of substantia nigra pigmented cell clusters in the human. Neuroscience. 68(2). 539–551. 43 indexed citations
17.
Halliday, Glenda M., L. Davies, D.A. McRitchie, et al.. (1995). Ubiquitin-positive achromatic neurons in corticobasal degeneration. Acta Neuropathologica. 90(1). 68–75. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026